ESR1 and breast carcinoma: We next sought to use DGCA to make a global comparison of gene expression correlation patterns between estrogen receptor-positive (ER+) and triple-negative (TN) breast cancers in TCGA (n = 625 ER+ samples, n = 89 TN samples).